Skip to main content

Point Windward Advisors Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1356202 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$1,013,878
-$155,436 QoQ
Shares Held
8,025
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,060
of 2,266 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Point Windward Advisors Inc. holds $16,439,542 across 6 Drug Manufacturers - General names. GILD ranks #5 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GILD
Gilead Sciences, Inc.
This page
8,025 $1,013,878

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,013,878 8,025
2026-03-31 $1,169,314 8,390
2025-12-31 $1,164,557 9,488
2025-09-30 $1,096,458 9,878
2025-06-30 $1,223,228 11,033
2025-03-31 $1,589,765 14,188
2024-12-31 $1,315,625 14,243
2024-09-30 $1,223,057 14,588
2024-06-30 $985,376 14,362
2024-03-31 $1,102,192 15,047
2023-12-31 $1,171,566 14,462
2023-09-30 $1,079,285 14,402
2023-06-30 $1,094,779 14,205
2023-03-31 $1,012,648 12,205
2022-12-31 $1,095,875 12,765
2022-09-30 $787,472 12,765
2022-06-30 $777,878 12,585
2022-03-31 $699,132 11,760
2021-12-31 $785,640 10,820